ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Incorporation of Donor Liver Macrovesicular Steatosis Into Srtr Risk Adjustment Models for Deceased Donor Yield and Post-Transplant Outcome

A. Kwong1, C. Wang2, A. Wey3, N. Salkowski3, J. Snyder4, J. Wetmore2, A. Israni2, J. Lake4, P. Stock5, W. Kim1

1Stanford University, Redwood City, CA, 2Medicine, Hennepin Healthcare, Minneapolis, MN, 3Scientific Registry of Transplant Recipients, Minneapolis, MN, 4University of Minnesota, Minneapolis, MN, 5University of California, San Francisco, San Francisco, CA

Meeting: 2021 American Transplant Congress

Abstract number: 104

Keywords: Allocation, Donors, marginal, Graft survival, Liver grafts

Topic: Clinical Science » Public Policy » Non-Organ Specific: Public Policy & Allocation

Session Information

Session Name: Potpourri of Public Policy and Allocation

Session Type: Rapid Fire Oral Abstract

Date: Sunday, June 6, 2021

Session Time: 4:30pm-5:30pm

 Presentation Time: 4:35pm-4:40pm

Location: Virtual

*Purpose: The SRTR had not traditionally included biopsy results in post-transplant risk adjustment, yet biopsy results may influence outcomes and thus decisions regarding organ acceptance. The aim of this study was to evaluate the impact of donor macrovesicular steatosis on organ yield and graft outcome after liver transplantation, and the effect of incorporating this variable into SRTR risk adjustment models for organ yield and program-specific graft outcomes.

*Methods: This study used data from the Scientific Registry of Transplant Recipients, which includes all donors, waitlisted candidates, and transplant recipients in the United States. We examined the association between macrovesicular steatosis and deceased donor yield, and the relationship between macrovesicular steatosis and 1-year posttransplant graft outcome using multivariable logistic regression and Cox models with the least absolute shrinkage and selection operator (LASSO).

*Results: 3.3% of donors had 31-50% macrovesicular steatosis on liver biopsy, and 1.3% with >50%. Increasing levels of steatosis on donor liver biopsy predicted lower organ yield; 31-50% and >50% macrovesicular steatosis was associated with 88 and 96% lower odds of utilization, respectively (Figure A). The risk of posttransplant graft failure with donor livers with >30% macrovesicular steatosis was 30% higher (HR 1.30), compared to those with no pre-transplant liver biopsy or those with 0-10% macrovesicular steatosis (Figure B). There was minimal change on organ procurement organization (OPO)-specific deceased donor yield or program-specific post-transplant outcome assessments when macrovesicular steatosis was added to the existing SRTR risk adjustment models.

*Conclusions: Macrovesicular steatosis is associated with lower organ yield and reduced graft survival. This risk factor has been added to the SRTR risk adjustment models for OPO and program-specific assessments and may facilitate more judicious use of these higher-risk organs.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kwong A, Wang C, Wey A, Salkowski N, Snyder J, Wetmore J, Israni A, Lake J, Stock P, Kim W. Incorporation of Donor Liver Macrovesicular Steatosis Into Srtr Risk Adjustment Models for Deceased Donor Yield and Post-Transplant Outcome [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/incorporation-of-donor-liver-macrovesicular-steatosis-into-srtr-risk-adjustment-models-for-deceased-donor-yield-and-post-transplant-outcome/. Accessed May 9, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences